Stem Cell Reports · 2016 · 50 citations · 34 references
MedicineCell BiologyPathobiologyBone MetabolismCell SignalingSignal TransductionAdipocyte DifferentiationBone FormationBone HealthOsteoclast BiologyOsteogenesisOsteoporosisBone Marrow - Derived CellsBone Marrow Mesenchymal Stem CellsBone Marrow-derived Mesenchymal Stromal CellsMarrow FatNf-κb SignalingOsteogenic DifferentiationOsteoprotegerin SignalingP38 Mitogen-activated Protein Kinase Signaling
Bone marrow-derived mesenchymal stromal cells (BM-MSCs) are capable of differentiating into osteoblasts, chondrocytes, and adipocytes. Skewed differentiation of BM-MSCs contributes to the pathogenesis of osteoporosis. Yet how BM-MSC lineage commitment is regulated remains unclear. We show that ablation of p38α in Prx1+ BM-MSCs produced osteoporotic phenotypes, growth plate defects, and increased bone marrow fat, secondary to biased BM-MSC differentiation from osteoblast/chondrocyte to adipocyte and increased osteoclastogenesis and bone resorption. p38α regulates BM-MSC osteogenic commitment through TAK1-NF-κB signaling and osteoclastogenesis through osteoprotegerin (OPG) production by BM-MSCs. Estrogen activates p38α to maintain OPG expression in BM-MSCs to preserve the bone. Ablation of p38α in BM-MSCs positive for Dermo1, a later BM-MSC marker, only affected osteogenic differentiation. Thus, p38α mitogen-activated protein kinase (MAPK) in Prx1+ BM-MSCs acts to preserve the bone by promoting osteogenic lineage commitment and sustaining OPG production. This study thus unravels previously unidentified roles for p38α MAPK in skeletal development and bone remodeling.
34
CXCL12 in early mesenchymal progenitors is required for haematopoietic stem-cell maintenance
Adam Greenbaum, Yen‐Michael S. Hsu, Ryan B. Day et al. · Nature · 2013 · 1.3K citations · Full text
TAZ, a Transcriptional Modulator of Mesenchymal Stem Cell Differentiation
Jeong‐Ho Hong, Eun Sook Hwang, Michael T. McManus et al. · Science · 2005 · 1K citations